 |
- Technische Daten
- Im Angebot als 1 mg (sc-294594) und 5 mg (sc-294594A) sizes
- CAS Nummer: 939055-18-2
- Molekulargewicht: 421.5
- Summenformel: C23H24FN5O2
- Reinheit: ≥98%
- Physisches Aussehen: A crystalline solid
- SMILES: C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCNC(=O)C4=CC5=C(N4)C=
CC(=C5)F
- Beschreibung
- Isoforms of phospholipase D (PLD) cleave the head group from phospholipids, releasing the second messenger phosphatidic acid (PA), which can produce changes in Ras activation, cell spreading, stress fiber formation, chemotaxis, and membrane vesicle trafficking. FIPI is a derivative of halopemide which potently inhibits both PLD1 (IC50 = 25 nM) and PLD2 (IC50 = 20 nM). It also prevents PLD regulation of F-actin cytoskeleton reorganization, cell spreading, and chemotaxis. FIPI has good pharmacokinetic parameters in rats, with a half-life greater than five hours, a Cmax that, at 363 nM, is greater than 10-fold the IC50 versus PLD2, and bioavailability of 18%
- LAGERUNG:
- Ausschließlich für Forschungszwecke (in-vitro, laboratory research use only)
- Weitere Referenznummern
- Literaturhinweise
- 1 Su, W., Yeku, O., Olepu, S., et al. 5-fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol Pharmacol 75(3) 437-446 (2009).
2 Monovich, L., Mugrage, B., Quadros, E., et al. Optimization of halopemide for phospholipase D2 inhibition. Bioorg Med Chem Lett 17 2310-2311 (2007).
|
|
| |
Empfohlene Supportprodukte:
(Klicken Sie auf die gewünschte Anwendung um passenden Supportprodukte anzuzeigen.)
|
|
|
FIPI
Klicken Sie auf das Bild um es zu vergrößern.
|
|
|
Download
|
|
